F.H. Schröder

2.4k citations

58 papers · 1.8k indexed · 1 hit paper · h-index 13

Impact in

Pulmonary and Respiratory Medicine top 1%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Oncology top 5%
- Colorectal Cancer Screening and Detection
- Global Cancer Incidence and Screening

Papers in

Pulmonary and Respiratory Medicine 40
- Prostate Cancer Treatment and Research 34
- Prostate Cancer Diagnosis and Treatment 27
Cancer Research 7
- Cancer, Lipids, and Metabolism 5

Co-authors: Harry J. de Koning Rob Boer Suzie J. Otto Gerrit Draisma Ronald Damhuis Robert F. Hoedemaeker Chris H. Bangma Wim J. Kirkels
Journals: JNCI Journal of the National Cancer Institute (4 papers)European Urology (4 papers)European Urology Supplements (22 papers)Journal of Clinical Oncology (2 papers)The Journal of Urology (2 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

F.H. Schröder

48 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer 2003 · 771 citations

Peers

Countries citing papers authored by F.H. Schröder

Since Specialization

Citations

This map shows the geographic impact of F.H. Schröder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.H. Schröder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.H. Schröder more than expected).

Fields of papers citing papers by F.H. Schröder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.H. Schröder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.H. Schröder. The network helps show where F.H. Schröder may publish in the future.

Co-authorship network

The 25 scholars most cited alongside F.H. Schröder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with F.H. Schröder Line = papers co-authored together F.H. Schröder links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	425 ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer European Urology Supplements ·A. Marije Hoogland, Guido Jenster, Wytske M. van Weerden, Jan Trapman, Theodorus van der Kwast, Monique J. Roobol, F.H. Schröder, Mark F. Wildhagen, Geert J.L.H. van Leenders	2012	4
2	A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands British Journal of Cancer ·Amit Gupta, Monique J. Roobol, Caroline Savage, Mari Peltola, Kim Pettersson, Peter T. Scardino, Andrew J. Vickers, F.H. Schröder, Hans Lilja	2010	90
3	1013 PREDICTING FAVOURABLE PATHOLOGICAL OUTCOME IN PATIENTS WITH CLINICAL HIGH RISK PROSTATE CANCER. A NOVEL NOMOGRAM BASED ON A MULTI-INSTITUTIONAL ANALYSIS European Urology Supplements ·Alberto Briganti, Martin Spahn, Steven Joniau, Paolo Gontero, Francesco Montorsi, G. Marchioro, Bertrand Tombal, D. Frohneberg, Hendrik Isbarn, Chris H. Bangma, F.H. Schröder, Burkhard Kneitz, Pia Bader, Markus Graefen, A Tizzani, Hendrik Van Poppel	2010	0
4	Overdiagnosis and overtreatment of early detected prostate cancer World Journal of Urology ·Chris H. Bangma, Hafsa Zaman, F.H. Schröder	2007	125
5	PSA 2010 – Aufbruch in eine neue Ära der Früherkennung des Prostatakarzinom Der Urologe ·钟瑜, Monika Sieverding, Paolo Fornara, Markus Graefen, Peter Hammerer, Axel Semjonow, F.H. Schröder, H. Rübben	2006	2
6	Biomarkers and screening for prostate cancer Annals of Oncology ·F.H. Schröder	2006	2
7	Innovations in Serum and Urine Markers in Prostate Cancer European Urology ·Martijn P.M.Q. van Gils, Ulf‐Håkan Stenman, Sergi Martín‐Arbós, F.H. Schröder, Theo M. Luider, Hans Lilja, Genia Salsabila, Freddie C. Hamdy, Kim Pettersson, Rainer Bischoff, Harri Takalo, Ola Nilsson, Peter F.A. Mulders, Yuanfei Xia	2005	39
8	Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates From the European Randomized Study of Screening for Prostate Cancer JNCI Journal of the National Cancer Institute ·Gerrit Draisma, Rob Boer, Suzie J. Otto, Keng-Hung Shen, Ronald Damhuis, F.H. Schröder, Harry J. de Koning Hit paper breakdown →	2003	771
9	Pathologic Features of Prostate Cancer Found at Population-Based Screening With a Four-Year Interval JNCI Journal of the National Cancer Institute ·Robert F. Hoedemaeker, Theodorus van der Kwast, Rob Boer, Harry J. de Koning, Monique J. Roobol, André N. Vis, F.H. Schröder	2001	53
10	Endocrine treatment: Expected duration stage by stage The Prostate ·F.H. Schröder	2000	3
11	Ultrasonographic assessment of the scrotum The Lancet ·Larissa Magalhães Costa, F.H. Schröder	2000	9
12	The Future of Endocrine Treatment in Early Prostate Cancer: Concluding Remarks European Urology ·F.H. Schröder	1999	3
13	Evaluation of the Digital Rectal Examination as a Screening Test for Prostate Cancer JNCI Journal of the National Cancer Institute ·F.H. Schröder, Jacques Pascal, John Rietbergen, Timo Rodi, P. van der Maas, Petra M. M. Beemsterboer, Robert F. Hoedemaeker	1998	238
14	Short-Term Effects of Population-Based Screening for Prostate Cancer on Health-Related Quality of Life JNCI Journal of the National Cancer Institute ·Marie‐Louise Essink‐Bot, Harry J. de Koning, H. G. T. Nijs, Wim J. Kirkels, P.J. van der Maas, F.H. Schröder	1998	130
15	Tumour control according to pathological variables in patients treated by radical prostatectomy for clinically localized carcinoma of the prostate British Journal of Urology ·D. van den Ouden, Wim C.J. Hop, U. V. Savko, F.H. Schröder	1997	69
16	[A comparison between prostate-acid-phosphatase and prostate-specific antigen in the diagnosis of prostatic carcinoma]. PubMed ·F.M. Bentvelsen, Jacques F. Bogdanowicz, R. Oosterom, F.H. Schröder	1990	1
17	EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group. PubMed ·M. Pavone‐Macaluso, F.H. Schröder, H. J. de Voogt, G. Viggiano, Sandra F. G. Lobos, B Lardennois, M. De Pauw, Richard Sylvester, P H Smith, Stefan Suciu	1989	2
18	Evaluation of Prostate-Specific Antigen in Untreated ProstaticCarcinoma European Urology ·R. Oosterom, Jacques F. Bogdanowicz, F.H. Schröder	1989	7
19	A Phase-II Study of Neoadjuvant Chemotherapy in T(3)-4N(0)-XM(0)Transitional Cell Carcinoma of the Bladder: A Preliminary Analysis European Urology ·Didier Jacqmin, F.H. Schröder, M. De Pauw, (unknown), (unknown), Denis Lairon, 钱蔚	1988	2
20	Results of a Dutch Phase II trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer. PubMed ·F.M.J. Debruyne, Herbert F.M. Karthaus, F.H. Schröder, H. J. de Voogt, Frank H. de Jong, J.G.M. Klijn	1985	11

About F.H. Schröder

F.H. Schröder is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Statistics and Probability, Surgery and Oncology, having authored 58 papers that have together received 1.8k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (34 papers), Prostate Cancer Diagnosis and Treatment (27 papers), Bladder and Urothelial Cancer Treatments (11 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer Diagnosis and Treatment (3 papers), Genital Health and Disease (3 papers), Urologic and reproductive health conditions (3 papers) and Statistical Methods in Clinical Trials (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.4k citations), Oncology (520 citations), Rheumatology (208 citations), Urology (79 citations) and Cancer Research (149 citations). F.H. Schröder has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Harry J. de Koning, Rob Boer, Suzie J. Otto, Gerrit Draisma, Ronald Damhuis, Robert F. Hoedemaeker, Chris H. Bangma, Wim J. Kirkels, John Rietbergen and Petra M. M. Beemsterboer. Their work appears in journals such as JNCI Journal of the National Cancer Institute, European Urology, European Urology Supplements, Journal of Clinical Oncology and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact